Retraction : MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2
Copyright: © 2022 Li et al..
[This retracts the article DOI: 10.18632/oncotarget.21069.].
| Errataetall: |
RetractionOf: Oncotarget. 2017 Sep 16;8(53):91530-91541. - PMID 29207663 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Oncotarget - 13(2022) vom: 05., Seite 863 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Na [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.07.2022 published: Electronic-eCollection RetractionOf: Oncotarget. 2017 Sep 16;8(53):91530-91541. - PMID 29207663 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18632/oncotarget.28253 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343337568 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343337568 | ||
| 003 | DE-627 | ||
| 005 | 20231226020221.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.28253 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1144.xml |
| 035 | |a (DE-627)NLM343337568 | ||
| 035 | |a (NLM)35813282 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Na |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction |b MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a RetractionOf: Oncotarget. 2017 Sep 16;8(53):91530-91541. - PMID 29207663 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2022 Li et al. | ||
| 520 | |a [This retracts the article DOI: 10.18632/oncotarget.21069.] | ||
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Wang, Lufei |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Guangyun |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Zhiheng |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Lei |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ming |e verfasserin |4 aut | |
| 700 | 1 | |a He, Jin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 13(2022) vom: 05., Seite 863 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g day:05 |g pages:863 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.28253 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |b 05 |h 863 | ||